Table 1.

Summary of demographics and baseline characteristics

Category	Placebo		Fidaxomicin
	Japanese (n = 6)	Caucasian (n = 3)	Japanese 100 mg (n = 9)	Japanese 200 mg (n = 9)	Caucasian 200 mg (n = 9)	Total (n = 27)
Sex [n (%)]
Male	6 (100.0)	3 (100.0)	9 (100.0)	9 (100.0)	9 (100.0)	27 (100.0)
Ethnicity [n (%)]
Not Hispanic or Latino	6 (100.0)	3 (100.0)	9 (100.0)	9 (100.0)	9 (100.0)	27 (100.0)
Asian	6 (100.0)	0	9 (100.0)	9 (100.0)	0	18 (66.7)
Race [n (%)]
White	0	3 (100.0)	0	0	9 (100.0)	9 (33.3)
Age (years) [mean ± SD]	34.3 ± 3.7	36.7 ± 13.8	36.6 ± 10.6	34.2 ± 10.3	32.6 ± 8.8	34.4 ± 9.7
Height (cm) [mean ± SD]	169.6 ± 6.6	177.7 ± 10.7	170.8 ± 7.3	171.0 ± 6.6	176.1 ± 10.1	172.6 ± 8.2
Weight (kg) [mean ± SD]	71.7 ± 8.9	78.4 ± 15.8	67.9 ± 8.9	70.8 ± 9.2	78.7 ± 10.8	72.5 ± 10.4
BMI (kg/m2) [mean ± SD]	24.9 ± 2.1	24.6 ± 2.5	23.2 ± 2.0	24.2 ± 2.6	25.5 ± 3.8	24.3 ± 2.9

BMI body mass index, SD standard deviation